Rosenfeld J, Boner G, Wainer E
Br J Clin Pharmacol. 1982;13(Suppl 2):237S-240S. doi: 10.1111/j.1365-2125.1982.tb01920.x.
1 In an acute study in hypertensive patients with normal and decreased renal function the i.v. administration of pindolol (0.1 mg/kg) caused a decrease in inulin clearance and a concomitant but not significant decrease in PAH clearance with a constant filtration fraction. 2 The long-term administration of pindolol (5--20 mg/day) to hypertensive patients with normal renal function was not associated with changes in renal function but in patients with a decreased renal function, pindolol caused an increase in PAH clearance but no change in inulin clearance.
1 在一项针对肾功能正常和肾功能下降的高血压患者的急性研究中,静脉注射吲哚洛尔(0.1毫克/千克)导致菊粉清除率下降,同时PAH清除率有伴随性下降,但滤过分数恒定,下降并不显著。2 对肾功能正常的高血压患者长期给予吲哚洛尔(5 - 20毫克/天)与肾功能变化无关,但对肾功能下降的患者,吲哚洛尔导致PAH清除率增加,而菊粉清除率无变化。